Transcatheter Pulmonary Valve Replacement With the Melody Valve in Small Diameter Expandable Right Ventricular Outflow Tract Conduits

Shabana Shahanavaz, Athar M. Qureshi, Daniel S. Levi, Younes Boudjemline, Lynn F. Peng, Mary Hunt Martin, Holly Bauser-Heaton, Britton Keeshan, Jeremy D. Asnes, Thomas K. Jones, Henri Justino, Jamil A. Aboulhosn, Robert G. Gray, Hoang Nguyen, David T. Balzer, Doff B. McElhinney

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Objectives: This study sought to evaluate the safety, feasibility, and outcomes of transcatheter pulmonary valve replacement (TPVR) in conduits ≤16 mm in diameter. Background: The Melody valve (Medtronic, Minneapolis, Minnesota) is approved for the treatment of dysfunctional right ventricular outflow tract (RVOT) conduits ≥16 mm in diameter at the time of implant. Limited data are available regarding the use of this device in smaller conduits. Methods: The study retrospectively evaluated patients from 9 centers who underwent percutaneous TPVR into a conduit that was ≤16 mm in diameter at the time of implant, and reported procedural characteristics and outcomes. Results: A total of 140 patients were included and 117 patients (78%; median age and weight 11 years of age and 35 kg, respectively) underwent successful TPVR. The median original conduit diameter was 15 (range: 9 to 16) mm, and the median narrowest conduit diameter was 11 (range: 4 to 23) mm. Conduits were enlarged to a median diameter of 19 mm (29% larger than the implanted diameter), with no difference between conduits. There was significant hemodynamic improvement post-implant, with a residual peak RVOT pressure gradient of 7 mm Hg (p < 0.001) and no significant pulmonary regurgitation. During a median follow-up of 2.0 years, freedom from RVOT reintervention was 97% and 89% at 2 and 4 years, respectively, and there were no deaths and 5 cases of endocarditis (incidence rate 2.0% per patient-year). Conclusions: In this preliminary experience, TPVR with the Melody valve into expandable small diameter conduits was feasible and safe, with favorable early and long-term procedural and hemodynamic outcomes.

Original languageEnglish
Pages (from-to)554-564
Number of pages11
JournalJACC: Cardiovascular Interventions
Issue number6
StatePublished - Mar 26 2018


  • allograft
  • bovine jugular vein conduit
  • percutaneous valve
  • pulmonary artery
  • stent
  • tetralogy of Fallot


Dive into the research topics of 'Transcatheter Pulmonary Valve Replacement With the Melody Valve in Small Diameter Expandable Right Ventricular Outflow Tract Conduits'. Together they form a unique fingerprint.

Cite this